Kim DE - Search Results

1

Synergistic two-step inhibition approach using a combination of trametinib and onvansertib in KRAS and TP53-mutated colorectal adenocarcinoma.

Kim DE, Oh HJ, Kim HJ, Kim YB, Kim ST, Yim H. Kim DE, et al. Biomed Pharmacother. 2025 Jan;182:117796. doi: 10.1016/j.biopha.2024.117796. Epub 2024 Dec 28. Biomed Pharmacother. 2025. PMID: 39731938 Free article.

2

Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis.

Kim CH, Kim DE, Kim DH, Min GH, Park JW, Kim YB, Sung CK, Yim H. Kim CH, et al. Among authors: kim de, kim dh, kim yb. Exp Mol Med. 2022 Apr;54(4):414-425. doi: 10.1038/s12276-022-00750-y. Epub 2022 Apr 4. Exp Mol Med. 2022. PMID: 35379935 Free PMC article. Review.

3

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC.

Kim DE, Shin SB, Kim CH, Kim YB, Oh HJ, Yim H. Kim DE, et al. Among authors: kim ch, kim yb. Theranostics. 2023 Feb 5;13(3):1198-1216. doi: 10.7150/thno.79318. eCollection 2023. Theranostics. 2023. PMID: 36793862 Free PMC article.

4

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma.

Jang HR, Shin SB, Kim CH, Won JY, Xu R, Kim DE, Yim H. Jang HR, et al. Among authors: kim de, kim ch. Cell Death Differ. 2021 Sep;28(9):2745-2764. doi: 10.1038/s41418-021-00781-4. Epub 2021 May 7. Cell Death Differ. 2021. PMID: 33963314 Free PMC article.

5

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters.

Shin SB, Kim DH, Kim DE, Aldonza MBD, Kim Y, Yim H. Shin SB, et al. Among authors: kim de, kim dh, kim y. Cancers (Basel). 2021 Sep 1;13(17):4413. doi: 10.3390/cancers13174413. Cancers (Basel). 2021. PMID: 34503223 Free PMC article.

6

Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition.

Xu R, Won JY, Kim CH, Kim DE, Yim H. Xu R, et al. Among authors: kim de, kim ch. J Oncol. 2019 Jun 2;2019:5810465. doi: 10.1155/2019/5810465. eCollection 2019. J Oncol. 2019. PMID: 31275381 Free PMC article. Review.

7

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma.

Jang HR, Shin SB, Kim CH, Won JY, Xu R, Kim DE, Yim H. Jang HR, et al. Among authors: kim de, kim ch. Cell Death Differ. 2022 Oct;29(10):2106. doi: 10.1038/s41418-021-00842-8. Cell Death Differ. 2022. PMID: 34404920 Free PMC article. No abstract available.

8

Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21^cip1 signaling in acute kidney injury.

Kim DE, Byeon HE, Kim DH, Kim SG, Yim H. Kim DE, et al. Among authors: kim dh, kim sg. Cell Biol Toxicol. 2023 Aug;39(4):1509-1529. doi: 10.1007/s10565-022-09741-1. Epub 2022 Jul 16. Cell Biol Toxicol. 2023. PMID: 35842499 Free PMC article.

9

Effect of echinalkamide identified from Echinacea purpurea (L.) Moench on the inhibition of osteoclastogenesis and bone resorption.

Chang BY, Lee SK, Kim DE, Bae JH, Ho TT, Park SY, Lee MK, Kim SY. Chang BY, et al. Among authors: kim de, kim sy. Sci Rep. 2020 Jul 2;10(1):10914. doi: 10.1038/s41598-020-67890-x. Sci Rep. 2020. PMID: 32616823 Free PMC article.

10

Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.

Nam G, Jung JM, Park HJ, Baek SY, Baek KS, Mok HY, Kim DE, Jung YH. Nam G, et al. Among authors: kim de. Bioorg Med Chem. 2019 Aug 1;27(15):3408-3420. doi: 10.1016/j.bmc.2019.06.036. Epub 2019 Jun 20. Bioorg Med Chem. 2019. PMID: 31235266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters